gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · ECORHealthcareElectromedical Equipment

electroCore, Inc. Common Stock (ECOR)

$8.40+16.18%
Close Nov 4, 2026 · split-adjusted
Nov 3, 2026$7.23▲ 42.32% in range
Nov 3, 2025Low $4.42 · High $12.29Nov 3, 2026
What changed · written from our data
As of Nov 4, 2026

electroCore closed at $8.40 on Nov 4, up 16.18%, 31.7% below its 52-week closing high. Volume of 239.3K shares was 3.02× its 20-day average (well above normal).

Split-adjusted performance: -15.3% over one month, +26.1% over six months, +65.4% over one year.

In the quarter ended Jun 30, 2026, revenue was $9.45M, up 28.0% from a year earlier, with a net margin of -32.4%.

Short interest was 347.7K shares at the Oct 15 settlement, up 10.6% from the prior report (5.9% of float, 4.4 days to cover).

Market cap$75.7M9.0M shares
Revenue · quarter$9.4M+28.0% YoY
Diluted EPS$-0.33—
P/E · TTM—P/S 2.0×
Net margin-32.4%Gross 86.5%
Dividend yieldNone
52-week range4.42 – 12.29−31.7% from high
Volume239.3K3.02× 20-day avg
Volatility · 60d72.5%Annualised
Short % of float5.9%4.4 days to cover
Net cash$3.3MCash $10.0M
Next earnings—Not scheduled
Split-adjusted performance
1W −0.2%1M −15.3%3M +25.4%6M +26.1%YTD +87.3%1Y +65.4%3Y +36.6%5Y −41.2%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Electromedical Equipment

Percentile among 22 companies (100 = best)

6-month momentum76
Revenue growth71
Net margin53
Value (low P/E)—
Size33

Industry medians: 6-month return −0.9%, revenue growth +13.9%, net margin −44.6%, P/E 23.7×.

Short interest

Details →
Shares short347.7K+10.6% vs prior
Days to cover4.4Settled Oct 15
% of float5.9%
Short vol. 10d46.1%of daily volume

Closest peers by size in Electromedical Equipment

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
ECORelectroCore$8.40+16.18%+26.1%+28.0%−32.4%—$75.7M
HYPRHyperfine$0.7503+8.36%−56.6%+44.8%−238.2%—$79.6MCompare
OMOutset Medical$4.44+6.99%−1.6%+0.7%−56.8%—$83.5MCompare
NRXSNeuraxis$6.86+4.26%−22.1%+115.7%−118.1%—$86.1MCompare
STXSStereotaxis$0.9572+13.55%−50.1%−12.8%−62.3%—$95.9MCompare
VANIVivani Medical, Inc. Common Stock (DE)$1.07+1.90%−14.4%———$96.5MCompare
POCIPrecision Optics$4.84+3.42%+2.8%+42.0%−1.2%—$53.2MCompare
STEXStreamex$0.3610−5.00%−64.3%—−9968.5%—$42.0MCompare
QTIQT Imaging Holdings$2.19+1.39%−69.2%+103.2%−148.9%—$32.1MCompare

News about electroCore

All news →
electroCore (ECOR) Stock Jumps 6.9%: Will It Continue to Soar?Zacks Investment Research · Sep 18, 2026▲ PositiveelectroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClubGlobeNewswire Inc. · Jun 2, 2026▲ PositiveelectroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026GlobeNewswire Inc. · May 9, 2026▲ PositiveelectroCore to Present at the Market Movers Investor Summit on May 5, 2026GlobeNewswire Inc. · Apr 28, 2026▲ PositiveelectroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSDGlobeNewswire Inc. · Apr 1, 2026▲ Positive

Quick answers

What does electroCore do?
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell.
What is ECOR's market cap?
$75.73M, based on the Nov 4 close of $8.40.
Does electroCore pay a dividend?
No regular cash dividend has been paid in the last year.
How much of ECOR is sold short?
347.7K shares, 5.9% of float, as of Oct 15, 2026.
What sector is ECOR in?
Healthcare, in the Electromedical Equipment industry.

About electroCore

electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.

HQ: Rockaway, NJ83 employeesListed Jun 22, 2018electrocore.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology